Tecentriq (atezolizumab) is a monoclonal antibody that affects the actions of the body's immune system. Atezolizumab strengthens your immune system to help your body fight against tumor cells.
Tecentriq is used to treat adults with:
a type of cancer of the bladder and urinary tract called urothelial carcinoma
a type of lung cancer called non-small cell lung cancer (NSCLC)
a type of breast cancer called triple-negative breast cancer (TNBC)
a type of lung cancer called small cell lung cancer (SCLC)
a type of liver cancer called hepatocellular carcinoma (HCC)
a type of skin cancer called melanoma.
Tecentriq is used when the cancer has spread to other parts of the body (metastatic), or cannot be removed by surgery.
Your doctor may perform a biopsy to test your cancer for a protein called "PD-L1," or a specific genetic marker (an abnormal "EGFR" or "ALK" or "BRAF" gene).
Tecentriq is sometimes given after other cancer treatments have not worked or have stopped working. Tecentriq may be given in combination with chemotherapy medicines.
